B. Canaud, Principes et modalités d’application de l’hémodialyse au traitement de l’insuffisance rénale chronique, EMconsulte néphrologie, vol.18, issue.10, 2006.

D. Falkenhagen, Correlation between ACT and iCa in RDT-patients, poster EDTA, p.318, 2011.

C. Ridel, Regional Citrate Anticoagulation during Hemodialysis, Blood Purification, vol.23, issue.6, pp.473-480, 2006.
DOI : 10.1159/000089652

M. Laville, T. Hannedouche, G. Deschenes, D. Glotz, and J. Grunfeld, Les ??tats g??n??raux du rein??: une occasion unique pour la n??phrologie fran??aise, N??phrologie & Th??rapeutique, vol.8, issue.4, pp.197-198, 2012.
DOI : 10.1016/j.nephro.2012.05.003

T. Petitclerc and B. Coevoet, Ionic dialysance and quality control in hemodialysis, Nephrologie, vol.22, issue.5, pp.191-197, 2001.

B. Canaud, Principes et modalités d'application de l'hémodialyse au traitement de l'insuffisance rénale chronique, EMconsulte Nephrologie, vol.18, issue.063, p.10, 2006.

T. Petitclerc, R. Diab, L. Roy, F. Mercadal, L. Hmida et al., H??modialyse sans ac??tate??: qu???est-ce vraiment???, N??phrologie & Th??rapeutique, vol.7, issue.2, pp.92-98, 2011.
DOI : 10.1016/j.nephro.2010.10.008

A. Amore, P. Cirina, S. Mitola, L. Peruzzi, R. Bonaudo et al., Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells, J Am Soc Nephrol, vol.8, issue.9, pp.1431-1436, 1997.

M. Noris, M. Todeschini, F. Casiraghi, D. Roccatello, G. Martina et al., Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension, American Journal of Kidney Diseases, vol.32, issue.1, pp.115-124, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9669432

T. Kuragano, A. Kida, M. Furuta, M. Yahiro, R. Kitamura et al., Effects of Acetate-Free Citrate-Containing Dialysate on Metabolic Acidosis, Anemia, and Malnutrition in Hemodialysis Patients, Artificial Organs, vol.66, issue.4, pp.282-290, 2012.
DOI : 10.1111/j.1525-1594.2011.01349.x

L. Mercadal, C. Ridel, and T. Petitclerc, Ionic dialysance: Principle and review of its clinical relevance for quantification of hemodialysis efficiency, Hemodialysis International, vol.127, issue.1, pp.111-119, 2005.
DOI : 10.1046/j.1525-1594.2002.06817.x

T. Petitclerc, Recent developments in conductivity monitoring of haemodialysis session, Nephrology Dialysis Transplantation, vol.14, issue.11, pp.2607-2613, 1999.
DOI : 10.1093/ndt/14.11.2607

T. Petitclerc, Do dialysate conductivity measurements provide conductivity clearance or ionic dialysance?, Kidney International, vol.70, issue.10, pp.1682-1686, 2006.
DOI : 10.1038/sj.ki.5001840

R. Lindsay, B. Bene, N. Goux, A. Heidenheim, C. Landgren et al., Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis, American Journal of Kidney Diseases, vol.38, issue.3, pp.565-574, 2001.
DOI : 10.1053/ajkd.2001.26874

A. Davenport, What are the anticoagulation options for intermittent hemodialysis? Nature reviews, Nephrology, vol.7, issue.9, pp.499-508, 2011.

T. Eegor, European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.6. Chronic graft dysfunction. Late recurrence of other diseases, Nephrol Dial Transplant, vol.17, issue.4, pp.18-19, 2002.

B. Guillet, N. Simon, J. Sampol, A. Lorec-penet, H. Portugal et al., Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis, Nephrology Dialysis Transplantation, vol.18, issue.11, pp.2348-2353, 2003.
DOI : 10.1093/ndt/gfg396

I. Jang and M. Hursting, When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia, Circulation, vol.111, issue.20, pp.2671-2683, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.518563

K. Polkinghorne, L. Mcmahon, and G. Becker, Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients, American Journal of Kidney Diseases, vol.40, issue.5, pp.990-995, 2002.
DOI : 10.1053/ajkd.2002.36331

S. Saxer, B. Smith, P. Gandhi, G. Tataronis, and S. Krikorian, Recommended and actual lepirudin doses in patients with renal insufficiency, Am J Health-syst Pharm, vol.60, issue.24, pp.2588-2593, 2003.

E. Lindhoff-last, C. Betz, and R. Bauersachs, Use of a Low-Molecular-Weight Heparinoid (Danaparoid Sodium) for Continuous Renal Replacement Therapy in Intensive Care Patients, Clinical and Applied Thrombosis/Hemostasis, vol.115, issue.4, pp.300-304, 2001.
DOI : 10.1177/107602960100700409

M. Haase, R. Bellomo, J. Rocktaeschel, S. Ziemer, H. Kiesewetter et al., Use of fondaparinux (ARIXTRA(R)) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II, Nephrology Dialysis Transplantation, vol.20, issue.2, pp.444-446, 2005.
DOI : 10.1093/ndt/gfh544

M. Balik, P. Waldauf, P. Plasil, and J. Pachl, Prostacyclin versus Citrate in Continuous Haemodiafiltration: An Observational Study in Patients with High Risk of Bleeding, Blood Purification, vol.23, issue.4, pp.325-329, 2005.
DOI : 10.1159/000087770

S. Kozek-langenecker, S. Kettner, C. Oismueller, C. Gonano, W. Speiser et al., Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration, Critical Care Medicine, vol.26, issue.7, pp.1208-1212, 1998.
DOI : 10.1097/00003246-199807000-00021

P. Glaser, R. Guesde, J. Rouby, and B. Eurin, H??MODIALYSIS WITHOUT HEPARIN IS POSSIBLE, The Lancet, vol.314, issue.8142, pp.579-580, 1979.
DOI : 10.1016/S0140-6736(79)91631-3

S. Sagedal, A. Hartmann, K. Osnes, S. Bjørnsen, J. Torremocha et al., Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin, Nephrology Dialysis Transplantation, vol.21, issue.2, pp.444-449, 2006.
DOI : 10.1093/ndt/gfi203

R. Klingel, M. Schaefer, A. Schwarting, F. Himmelsbach, U. Altes et al., Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation, Nephrology Dialysis Transplantation, vol.19, issue.1, pp.164-170, 2004.
DOI : 10.1093/ndt/gfg459

R. Swartz and F. Port, Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin, Kidney International, vol.16, issue.4, pp.513-518, 1979.
DOI : 10.1038/ki.1979.157

S. Morabito, I. Guzzo, A. Solazzo, L. Muzi, R. Luciani et al., Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding, J Nephrol, vol.16, issue.4, pp.566-571, 2003.

P. Van-der-voort, R. Gerritsen, M. Kuiper, P. Egbers, W. Kingma et al., Filter Run Time in CVVH: Pre- versus Post-Dilution and Nadroparin versus Regional Heparin-Protamine Anticoagulation, Blood Purification, vol.23, issue.3, pp.175-180, 2005.
DOI : 10.1159/000083938

D. Falkenhagen, Correlation between ACT and iCa in RDT-patients. poster, EDTA, vol.318, 2011.

M. Flanigan, V. Brecht, J. Freeman, R. Lim, and V. , Reducing the Hemorrhagic Complications of Hemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate Anticoagulation, American Journal of Kidney Diseases, vol.9, issue.2, pp.147-153, 1987.
DOI : 10.1016/S0272-6386(87)80092-6

R. Hofbauer, D. Moser, M. Frass, R. Oberbauer, A. Kaye et al., Effect of anticoagulation on blood membrane interactions during hemodialysis, Kidney International, vol.56, issue.4, pp.1578-1583, 1999.
DOI : 10.1046/j.1523-1755.1999.00671.x

D. Kutsogiannis, R. Gibney, D. Stollery, and J. Gao, Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients, Kidney International, vol.67, issue.6, pp.2361-2367, 2005.
DOI : 10.1111/j.1523-1755.2005.00342.x

P. Evenepoel, T. Dejagere, P. Verhamme, K. Claes, D. Kuypers et al., Heparin-Coated Polyacrylonitrile Membrane Versus Regional Citrate Anticoagulation: A Prospective Randomized Study of 2 Anticoagulation Strategies in Patients at Risk of Bleeding, American Journal of Kidney Diseases, vol.49, issue.5, pp.642-649, 2007.
DOI : 10.1053/j.ajkd.2007.02.001

M. Monchi, D. Berghmans, D. Ledoux, J. Canivet, B. Dubois et al., Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study, Intensive Care Medicine, vol.30, issue.2, pp.260-265, 2004.
DOI : 10.1007/s00134-003-2047-x

H. Oudemans-van-straaten, R. Bosman, M. Koopmans, P. Van-der-voort, J. Wester et al., Citrate anticoagulation for continuous venovenous hemofiltration*, Critical Care Medicine, vol.37, issue.2, pp.545-552, 2009.
DOI : 10.1097/CCM.0b013e3181953c5e

R. Apsner, H. Buchmayer, D. Gruber, and G. Sunder-plassmann, Citrate for long-term hemodialysis: Prospective study of 1,009 consecutive high-flux treatments in 59 patients, American Journal of Kidney Diseases, vol.45, issue.3, pp.557-564, 2005.
DOI : 10.1053/j.ajkd.2004.12.002

M. Janssen, J. Deegens, T. Kapinga, J. Beukhof, P. Huijgens et al., Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients, Kidney International, vol.49, issue.3, pp.806-813, 1996.
DOI : 10.1038/ki.1996.112

M. Janssen, P. Huijgens, A. Bouman, P. Oe, A. Donker et al., Citrate versus heparin anticoagulation in chronic haemodialysis patients, Nephrol Dial Transplant, vol.8, issue.11, pp.1228-1233, 1993.

Y. Morita, R. Johnson, R. Dorn, and D. Hall, REGIONAL ANTICOAGULATION DURING HEMODIALYSIS USING CITRATE, The American Journal of the Medical Sciences, vol.242, issue.2, pp.32-43, 1961.
DOI : 10.1097/00000441-196107000-00005

R. Pinnick, T. Wiegmann, and D. Diederich, Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for Bleeding, New England Journal of Medicine, vol.308, issue.5, pp.258-261, 1983.
DOI : 10.1056/NEJM198302033080506

R. Mehta, B. Mcdonald, M. Aguilar, and D. Ward, Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients, Kidney International, vol.38, issue.5, pp.976-981, 1990.
DOI : 10.1038/ki.1990.300

P. Evenepoel, B. Maes, J. Vanwalleghem, D. Kuypers, T. Messiaen et al., Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate, American Journal of Kidney Diseases, vol.39, issue.2, pp.315-323, 2002.
DOI : 10.1053/ajkd.2002.30551

R. Kossmann, A. Gonzales, R. Callan, and S. Ahmad, Increased Efficiency of Hemodialysis with Citrate Dialysate: A Prospective Controlled Study, Clinical Journal of the American Society of Nephrology, vol.4, issue.9, pp.1459-1464, 2009.
DOI : 10.2215/CJN.02590409

S. Ahmad, R. Callan, J. Cole, and C. Blagg, Dialysate made from dry chemicals using citric acid increases dialysis dose, American Journal of Kidney Diseases, vol.35, issue.3, pp.493-499, 2000.
DOI : 10.1016/S0272-6386(00)70203-4

L. Gabutti, B. Lucchini, C. Marone, L. Alberio, and M. Burnier, Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes, BMC Nephrology, vol.40, issue.1, p.7, 2009.
DOI : 10.1172/JCI107749

Y. Cheng, A. Yu, K. Tsang, D. Shah, C. Kjellstrand et al., Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study, Nephrology Dialysis Transplantation, vol.26, issue.2, pp.641-646, 2011.
DOI : 10.1093/ndt/gfq396

C. Ridel, L. Mercadal, B. Bene, A. Hamani, G. Deray et al., Regional Citrate Anticoagulation during Hemodialysis, Blood Purification, vol.23, issue.6, pp.473-480, 2005.
DOI : 10.1159/000089652

H. Adequacy-work and G. , Clinical practice guidelines for hemodialysis adequacy, update 2006, Am J Kidney Dis, vol.48, issue.1, pp.2-90, 2006.

P. Richtrova, K. Rulcova, J. Mares, and T. Reischig, Evaluation of Three Different Methods to Prevent Dialyzer Clotting Without Causing Systemic Anticoagulation Effect, Artificial Organs, vol.24, issue.7, pp.83-88, 2011.
DOI : 10.1111/j.1525-1594.2010.01038.x

F. Keller, J. Seemann, L. Preuschof, and G. Offermann, Risk Factors of System Clotting in Heparin-Free Haemodialysis, Nephrology Dialysis Transplantation, vol.5, issue.9, pp.802-807, 1990.
DOI : 10.1093/ndt/5.9.802

R. Caruana, R. Raja, J. Bush, M. Kramer, and S. Goldstein, Heparin free dialysis: Comparative data and results in high risk patients, Kidney International, vol.31, issue.6, pp.1351-1355, 1987.
DOI : 10.1038/ki.1987.149

R. Caruana, M. Smith, D. Clyne, J. Crow, J. Zinn et al., Controlled Study of Heparin versus Epoprostenol Sodium (Prostacyclin) as the Sole Anticoagulant for Chronic Hemodialysis, Blood Purification, vol.9, issue.5-6, pp.5-6296, 1991.
DOI : 10.1159/000170027

D. Geary, M. Gajaria, S. Fryer-keene, and J. Willumsen, Low-dose and heparin-free hemodialysis in children, Pediatric Nephrology, vol.83, issue.2, pp.220-224, 1991.
DOI : 10.1007/BF01095957

P. Sanders, H. Taylor, and J. Curtis, Hemodialysis Without Anticoagulation, American Journal of Kidney Diseases, vol.5, issue.1, pp.32-35, 1985.
DOI : 10.1016/S0272-6386(85)80132-3

J. Sands, P. Kotanko, J. Segal, C. Ho, L. Usvat et al., Effects of Citrate Acid Concentrate (Citrasate??) on Heparin N Requirements and Hemodialysis Adequacy: A Multicenter, Prospective Noninferiority Trial, Blood Purification, vol.33, issue.1-3, pp.1-3199, 2012.
DOI : 10.1159/000334157

B. Stegmayr, P. Jonsson, and D. Mahmood, A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation, The International Journal of Artificial Organs, vol.36, issue.1, pp.1-6, 2013.
DOI : 10.5301/ijao.5000172

J. Aniort, T. Petitclerc, and C. Creput, Safe Use of Citric Acid-Based Dialysate and Heparin Removal in Postdilution Online Hemodiafiltration, Blood Purification, vol.34, issue.3-4, pp.3-4336, 2012.
DOI : 10.1159/000345342

L. Mercadal, T. Petitclerc, B. Bene, M. Jaudon, and C. Jacobs, Duocart Biofiltration, ASAIO Journal, vol.45, issue.3, pp.151-156, 1999.
DOI : 10.1097/00002480-199905000-00009

H. Meier-kriesche, K. Finkel, J. Gitomer, T. Dubose, and J. , Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation, American Journal of Kidney Diseases, vol.33, issue.4, p.8, 1999.
DOI : 10.1016/S0272-6386(99)70249-0

D. Charney and R. Salmond, Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis, ASAIO Trans, vol.36, issue.3, pp.217-219, 1990.

S. Kelleher and G. Schulman, Severe Metabolic Alkalosis Complicating Regional Citrate Hemodialysis, American Journal of Kidney Diseases, vol.9, issue.3, pp.235-236, 1987.
DOI : 10.1016/S0272-6386(87)80061-6

F. Silverstein, J. Oster, G. Perez, B. Materson, R. Lopez et al., Metabolic alkalosis induced by regional citrate hemodialysis, ASAIO Trans, vol.35, issue.1, pp.22-25, 1989.

J. Buturovic, J. Gubensek, D. Cerne, and R. Ponikvar, Standard Citrate Versus Sequential Citrate/Anticoagulant-free Anticoagulation During Hemodialysis: A Randomized Trial, Artificial Organs, vol.36, issue.0, pp.77-81, 2008.
DOI : 10.1097/01.CCM.0000084871.76568.E6

J. Clark, G. Schulman, and T. Golper, Safety and Efficacy of Regional Citrate Anticoagulation During 8-Hour Sustained Low-Efficiency Dialysis, Clinical Journal of the American Society of Nephrology, vol.3, issue.3, pp.736-742, 2008.
DOI : 10.2215/CJN.03460807

M. Kreuzer, K. Bonzel, R. Buscher, G. Offner, J. Ehrich et al., Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding, Nephrology Dialysis Transplantation, vol.25, issue.10, pp.3337-3342, 2010.
DOI : 10.1093/ndt/gfq225

F. Maduell, F. Moreso, M. Pons, R. Ramos, J. Mora-macià et al., High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients, Journal of the American Society of Nephrology, vol.24, issue.3, pp.487-497, 2013.
DOI : 10.1681/ASN.2012080875

R. Apsner, W. Horl, and G. Sunder-plassmann, Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation, Blood, vol.97, issue.9, pp.2914-2915, 2001.
DOI : 10.1182/blood.V97.9.2914

M. Gritters, M. Grooteman, M. Schoorl, M. Schoorl, P. Bartels et al., Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis, Nephrology Dialysis Transplantation, vol.21, issue.1, pp.153-159, 2006.
DOI : 10.1093/ndt/gfi069

J. Bohler, P. Schollmeyer, B. Dressel, G. Dobos, and W. Horl, Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation, J Am Soc Nephrol, vol.7, issue.2, pp.234-241, 1996.

J. Renaux, M. Thomas, T. Crost, N. Loughraieb, and G. Vantard, Activation of the kallikrein-kinin system in hemodialysis: Role of membrane electronegativity, blood dilution, and pH, Kidney International, vol.55, issue.3, pp.1097-1103, 1999.
DOI : 10.1046/j.1523-1755.1999.0550031097.x